Millennium Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.2M | Buy |
99,000
+82,000
| +482% | +$20.4M | 0.01% | 1459 |
|
|
2025
Q4 | $4.09M | Sell |
17,000
-46,800
| -73% | -$12M | ﹤0.01% | 3230 |
|
|
2025
Q3 | $17.5M | Buy |
63,800
+30,400
| +91% | +$8.3M | 0.01% | 1804 |
|
|
2025
Q2 | $8.62M | Buy |
33,400
+12,400
| +59% | +$2.96M | ﹤0.01% | 2428 |
|
|
2025
Q1 | $4.7M | Sell |
21,000
-42,400
| -67% | -$9.9M | ﹤0.01% | 2923 |
|
|
2024
Q4 | $14.5M | Sell |
63,400
-81,700
| -56% | -$19.7M | 0.01% | 1803 |
|
|
2024
Q3 | $35.4M | Sell |
145,100
-33,600
| -19% | -$7.51M | 0.02% | 1070 |
|
|
2024
Q2 | $34.2M | Sell |
178,700
-235,500
| -57% | -$47.8M | 0.02% | 1054 |
|
|
2024
Q1 | $82M | Buy |
414,200
+364,200
| +728% | +$66.7M | 0.04% | 563 |
|
|
2023
Q4 | $8.6M | Buy |
50,000
+14,400
| +40% | +$2.21M | ﹤0.01% | 2319 |
|
|
2023
Q3 | $5.26M | Buy |
35,600
+9,800
| +38% | +$1.77M | ﹤0.01% | 2630 |
|
|
2023
Q2 | $5.64M | Buy |
+25,800
| New | +$5.75M | ﹤0.01% | 2572 |
|
|
2023
Q1 | – | Sell |
-10,300
| Closed | -$2.14M | – | 6779 |
|
|
2022
Q4 | $2.14M | Sell |
10,300
-4,700
| -31% | -$1.03M | ﹤0.01% | 3509 |
|
|
2022
Q3 | $3.27M | Buy |
+15,000
| New | +$3.41M | ﹤0.01% | 3299 |
|
|
2022
Q1 | – | Sell |
-5,000
| Closed | -$1.3M | – | 7393 |
|
|
2021
Q4 | $1.3M | Buy |
+5,000
| New | +$1.3M | ﹤0.01% | 4159 |
|
|
2021
Q2 | – | Sell |
-5,300
| Closed | -$1.03M | – | 7019 |
|
|
2021
Q1 | $1.03M | Buy |
+5,300
| New | +$1.06M | ﹤0.01% | 4196 |
|
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$1.92M | – | 4760 |
|
|
2020
Q2 | $1.92M | Buy |
+10,000
| New | +$1.64M | ﹤0.01% | 2567 |
|
|
2020
Q1 | – | Sell |
-20,000
| Closed | -$3.1M | – | 4372 |
|
|
2019
Q4 | $3.1M | Buy |
20,000
+10,000
| +100% | +$1.44M | ﹤0.01% | 2307 |
|
|
2019
Q3 | $1.35M | Buy |
10,000
+5,000
| +100% | +$655K | ﹤0.01% | 2685 |
|
|
2019
Q2 | $610K | Sell |
5,000
-10,000
| -67% | -$1.11M | ﹤0.01% | 3096 |
|
|
2019
Q1 | $1.56M | Buy |
15,000
+5,000
| +50% | +$516K | ﹤0.01% | 2573 |
|
|
2018
Q4 | $1.14M | Buy |
+10,000
| New | +$1.07M | ﹤0.01% | 2516 |
|
|
2018
Q3 | – | Sell |
-30,000
| Closed | -$3.11M | – | 4212 |
|
|
2018
Q2 | $3.11M | Buy |
+30,000
| New | +$3.04M | ﹤0.01% | 2109 |
|
|
2016
Q4 | – | Sell |
-30,000
| Closed | -$1.94M | – | 3661 |
|
|
2016
Q3 | $1.94M | Buy |
+30,000
| New | +$2M | ﹤0.01% | 1947 |
|
|
2014
Q2 | – | Sell |
-5,100
| Closed | -$228K | – | 3794 |
|
|
2014
Q1 | $228K | Sell |
5,100
-121,000
| -96% | -$5.43M | ﹤0.01% | 3126 |
|
|
2013
Q4 | $5.94M | Buy |
126,100
+8,100
| +7% | +$410K | 0.02% | 1033 |
|
|
2013
Q3 | $6.23M | Sell |
118,000
-287,200
| -71% | -$13.9M | 0.02% | 988 |
|
|
2013
Q2 | $18.3M | Buy |
+405,200
| New | +$19.2M | 0.06% | 349 |
|
Other funds holding RMD
VCM
VPM
DAM
Millennium Management's RMD Position: Q1 2026 in Review
Millennium Management increased its ResMed (RMD) stake by 20% in Q1 2026, buying an estimated $5.94M and bringing the position to 142,280 shares worth $31.9M. The position accounts for 0.01% of the portfolio, ranked #1173.
Millennium Management first reported a position in RMD in Q2 2013 and has held it in 41 quarters since. The position peaked at $138M in Q2 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Millennium Management held 142,280 shares of ResMed worth $31.9M as of Q1 2026.
- Millennium Management bought 23,838 ResMed shares in Q1 2026, an estimated $5.94M.
- ResMed made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1173 holding.
- Millennium Management first reported a position in ResMed in Q2 2013 and has held it in 41 quarters since.
- Millennium Management's ResMed position peaked at $138M in Q2 2023.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.